Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01617889 · ClinicalTrials.gov registry record · Phase 3
Healthy Term Infants Fed Milk-Based Formulas
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 17
- Enrollment target
NCT01617889: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT01617889 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 17 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01617889, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 17 participants
- Enrollment target
Study Summary
The objective is to assess the comparative fat and calcium absorption, and gastrointestinal (GI) tolerance in healthy normal term infants fed powdered milk-based formulas containing different fat blends.
Primary Outcome
as measured in stool
Interventions
- OTHER Experimental powdered milk-based infant formula with an alternate fat blend
- OTHER A powdered milk-based infant formula, standard fat blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-08 |
| Phase | Phase 3 |
What the finished NCT01617889 record still lists
NCT01617889 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental powdered milk-based infant formula with an alternate fat blend is the first listed.
NCT01617889 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01617889 about?
NCT01617889 is a clinical study titled "Healthy Term Infants Fed Milk-Based Formulas". The objective is to assess the comparative fat and calcium absorption, and gastrointestinal (GI) tolerance in healthy normal term infants fed powdered milk-based formulas containing different fat blends.
What is the current status of trial NCT01617889?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 17 participants. The study started on 2011-03. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01617889?
The interventions under investigation include: Experimental powdered milk-based infant formula with an alternate fat blend (OTHER), A powdered milk-based infant formula, standard fat blend (OTHER).
Who is sponsoring clinical trial NCT01617889?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01617889's enrollment target sits among peer trials
17 1971st of 2000 higher than 27 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia